Known targets — ChEMBL curated mechanism
ABCC9ABL1ACEACHEACVR1ADORA1ADORA2AADORA2BADORA3ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALOX5ATP4AATP4BBCRBTKCACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNB1CHRNDCHRNECHRNGCRBNCUL4ACXCR1CXCR2DDB1DDCDHFRDPP4DRD2DRD3DRD4EGFRERBB2ERBB4ESR1ESR2FDPSFKBP1AFLT1FLT3FLT4GARTGHSRGRIA1GRIA2GRIA3GRIA4GRIK1GRIK2GRIK3GRIK4GRIK5GRIN2AGSK3AGSK3BHDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IDH1IDH2IMPA1ITGA2BITGB3JAK1JAK2JAK3KCNJ11KCNK3KCNK9KDRKITMEN1METMMP1MMP13MMP7MMP8NANOD2NS5bODC1OPG057OPRD1OPRK1OPRM1PPARP1PARP2PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDGFRBPIK3CAPIK3CBPIK3CDPIK3CGPIK3R1PIK3R2PIK3R3PIK3R5PKLRPPARDPPATPTGS1PTGS2RBX1ROCK1ROCK2RRM1RRM2RRM2BSCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC10A2SLC5A2SLC6A2SLC6A3SLC6A4SLC9A3SYKTACR1THRATHRBTOP1TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TYK2TYMSVDRampCblablaT-3blaT-4blaT-5blaT-6blaUOE-1dacAdacBdacCfolAfolPftsIgyrAgyrBileSmecAmrcAmrcBmrdAparCparEpbp2pbp4pbpApbpFrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUthyAykgMykgO
The experimentally established mechanism targets of Sucrose. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 known ✓ | O00255 | 1/20 | 0.48 |
| ▸ | ADORA1 known ✓ | P30542 | 1/20 | 0.40 |
| ▸ | CDK1 | P06493 | 1/20 | 0.78 |
| ▸ | CCNB1 | P14635 | 1/20 | 0.78 |
| ▸ | CA2 | P00918 | 1/20 | 0.53 |
| ▸ | CA9 | Q16790 | 1/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.48 |
| ▸ | LDHA | P00338 | 1/20 | 0.43 |
| ▸ | TYR | P14679 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 1/20 | 0.41 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.40 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.39 |
| ▸ | GAA | P10253 | 1/20 | 0.38 |
| ▸ | POLB | P06746 | 1/20 | 0.38 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Sucrose SCHEMBL106974 | 0.98 | CDK1 (0.80) | CDK1CCNB1CA2CA9MEN1 | |
| Sucrose SCHEMBL20769817 | 0.98 | CDK1 (0.80) | CDK1CCNB1CA2CA9MEN1 | |
| Sucrose SCHEMBL28123662 | 0.98 | CDK1 (0.80) | CDK1CCNB1CA2CA9MEN1 | |
| Sucrose SCHEMBL3291651 | 0.98 | CDK1 (0.80) | CDK1CCNB1CA2CA9MEN1 | |
| Sucrose SCHEMBL2331570 | 0.98 | CDK1 (0.80) | CDK1CCNB1CA2CA9MEN1 | |
| Sucrose SCHEMBL2558633 | 0.98 | CDK1 (0.80) | CDK1CCNB1CA2CA9MEN1 | |
| Sucrose SCHEMBL28293033 | 0.97 | CDK1 (0.78) | CDK1CCNB1CA2CA9MEN1 | |
| Sucrose SCHEMBL27554146 | 0.97 | CDK1 (0.78) | CDK1CCNB1CA2CA9MEN1 | |
| Sucrose SCHEMBL2961001 | 0.97 | CDK1 (0.78) | CDK1CCNB1CA2CA9MEN1 | |
| Sucrose SCHEMBL5970806 | 0.97 | CDK1 (0.78) | CDK1CCNB1CA2CA9MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 96 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8460939-B2 | Method for producing purified hematinic iron-saccharidic complex and product produced | CHROMACEUTICAL ADVANCED TECHNOLOGIES, INC. (US) | 2013-06-11 | — | — | US | claimed |
| US-20120329750-A1 | METHOD FOR PRODUCING PURIFIED HEMATINIC IRON-SACCHARIDIC COMPLEX AND PRODUCT PRODUCED | CHROMACEUTICAL ADVANCED TECHNOLOGIES, INC. (US) | 2012-12-27 | — | — | US | claimed |
| CN-1473265-B | Method for producing purified hematinic iron-sugar complex and product production | CHROMACEUTICAL ADVANCED TECH | 2011-10-12 | — | — | CN | claimed |
| US-20110220539-A1 | SYNTHESIS OF HIGH MOLECULAR WEIGHT IRON-SACCHARIDIC COMPLEXES | CHROMACEUTICAL ADVANCED TECHNOLOGIES, INC. (US) | 2011-09-15 | — | — | US | claimed |
| US-7883897-B2 | separating and purifying the active hematinic species (AHS) present in iron-saccharidic compositions; lyophilization; useful for calculating molecular characteristics such as absolute molecular weight, molecular weight distribution, size, shape, morphology, and dimensional variations | CHROMACEUTICAL ADVANCED TECHNOLOGIES, INC. (US) | 2011-02-08 | — | — | US | claimed |
| EP-2275075-A2 | Method of measuring an iron-saccharidic complex | Chromaceutical Advanced Technologies, Inc. (US) | 2011-01-19 | — | — | EP | claimed |
| US-20100152131-A1 | METHOD FOR PRODUCING PURIFIED HEMATINIC IRON-SACCHARADIC COMPLEX AND PRODUCT PRODUCED | CHROMACEUTICAL ADVANCED TECHNOLOGIES, INC. (US) | 2010-06-17 | — | — | US | claimed |
| US-7687273-B2 | Method for producing purified hematinic iron-saccharidic complex and product produced | CHROMACEUTICAL ADVANCED TECHNOLOGIES, INC. (US) | 2010-03-30 | — | — | US | claimed |
| EP-1628986-A2 | SYNTHESIS OF HIGH MOLECULAR WEIGHT IRON-SACCHARIDIC COMPLEXES | Chromaceutical Advanced Technologies, Inc. (US) | 2006-03-01 | — | — | EP | claimed |
| US-20050272163-A1 | Method for producing purified hematinic iron-saccharidic complex and product produced | CHROMACEUTICAL ADVANCED TECHNOLOGIES, INC. (US) | 2005-12-08 | — | — | US | claimed |
| US-6939715-B2 | Method for producing purified hematinic iron-saccharidic complex and product produced | CHROMACEUTICAL ADVANCED TECHNOLOGIES, INC. (US) | 2005-09-06 | — | — | US | claimed |
| US-6929954-B2 | Method for producing purified hematinic iron-saccharidic complex and product produced | CHROMACEUTICAL ADVANCED TECHNOLOGIES, INC. (US) | 2005-08-16 | — | — | US | claimed |
| US-20050037996-A1 | Synthesis of high molecular weight iron-saccharidic complexes | CHROMACEUTICAL ADVANCED TECHNOLOGIES INC (US) | 2005-02-17 | — | — | US | claimed |
| WO-2005000210-A2 | SYNTHESIS OF HIGH MOLECULAR WEIGHT IRON-SACCHARIDIC COMPLEXES | CHROMACEUTICAL ADVANCED TECHNOLOGIES, INC. (US) | 2005-01-06 | — | — | WO | claimed |
| US-20040220141-A1 | Method for producing purified hematinic iron-saccharidic complex and product produced | CHROMACEUTICAL ADVANCED TECHNOLOGIES, INC. | 2004-11-04 | — | — | US | claimed |
| US-6773924-B2 | SUCH AS IRON HYDROXIDE AND SODIUM IRON GLUCONATE IN GLUCOSE; BLOOD DISORDERS; STORAGE STABILITY | CHROMACEUTICAL ADVANCED TECHNOLOGIES, INC. | 2004-08-10 | — | — | US | claimed |
| US-20040038930-A1 | Method for producing purified hematinic iron-saccharidic complex and product produced | CHROMACEUTICAL ADVANCED TECHNOLOGIES, (US) | 2004-02-26 | — | — | US | claimed |
| CN-1473265-A | Method for producing purified hematinic iron-sugar complex and product production | 色品先进技术股份有限公司 | 2004-02-04 | — | — | CN | claimed |
| EP-4392045-A1 | IRON COMPOSITIONS AND METHODS OF MAKING AND USING THEM | American Regent, Inc. (US) | 2024-07-03 | — | — | EP | disclosed |
| US-20020076821-A1 | Method for producing purified hematinic iron-saccharidic complex and product produced | CHROMACEUTICAL ADVANCED TECHNOLOGIES, INC., A CORP. OF MASSACHUSETTS | 2002-06-20 | — | — | US | disclosed |